We collected 3 pairs of lung cancer samples with different pathological responses to immunotherapy to validate the differential protein expression of marked genes of CEACAM5+ epithelial with western blot and immunohistochemistry (Fig. 8a). This evidence concerns the gene CEACAM5 and lung cancer.